Tesamorelin | GHRH Analogue | Research Grade

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH). PerformanceLabsUK supplies it strictly as a research reference material for in vitro laboratory investigation. Researchers must not use Tesamorelin for human or veterinary purposes.

Areas of Research Interest

• Researchers study it for its stimulation of physiological GH pulse patterns through endogenous pituitary mechanisms.
• Scientists show interest in it as a tool that avoids supraphysiological dynamics associated with exogenous GH administration.
• Body composition research also examines this peptide, particularly its relationship to visceral adipose tissue in metabolic models.
• Additionally, investigators explore its differential effects on abdominal versus peripheral fat compartments in research models.
• Age-related GH axis decline research also investigates it, given the associated decline in GH pulsatility.
• Researchers study its interaction between GH secretion, IGF-1 signalling, and metabolic substrate utilisation.

Primary Research Areas: GH Axis Regulation | Visceral Fat Research | Body Composition | Metabolic Health | Endocrine Biology

Researchers investigating the GH/IGF-1 axis may also wish to review our COA Library for third-party verified analytical data, alongside our related CJC-1295 + Ipamorelin research blend. For structural and chemical reference data, see the independent PubChem listing for Tesamorelin.

REGULATORY NOTICE
FOR LABORATORY RESEARCH USE ONLY — NOT INTENDED FOR HUMAN OR VETERINARY CONSUMPTION

Not a medicinal product, pharmaceutical, food supplement, or cosmetic. Not evaluated or approved by the MHRA, FDA, or any regulatory
authority for use in humans or animals. Must not be used for diagnostic, therapeutic, or preventative purposes.
Must be handled only by qualified professionals within a suitable research environment. By purchasing you confirm research-only use.
Purchasers must be 18+. PerformanceLabsUK accepts no liability for misuse.